HeartRhythm

APRIL 30, 2024

Atypical Atrial Flutter (AAFL) prevalence is increasing due to the escalating Atrial Fibrillation (AF) ablations and cardiac surgeries. We wanted to explore the outcome of the AAFL ablation, considering the recent changes in mapping and ablation.

Atrial Flutter 40

Atrial Flutter Ablation Electrophysiology Atrial Fibrillation 40

DAIC

DECEMBER 29, 2023

The trial will evaluate the outcomes of therapy provided with the FARAPULSE PFA System versus AADs, including device-or procedure-related adverse events, the rates of freedom from AF, atrial flutter, or atrial tachycardia, as well as AF burden – a measurement of the amount of AF an individual experiences. Circulation.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

Journal of Cardiovascular Electrophysiology

JANUARY 15, 2024

Abstract Introduction Atrial fibrillation and atrial flutter originating from the donor s heart is a commonly reported complication post heart transplant. Case A 47-year-old male presented with atrial tachycardia 6 months post heart transplant.

Atrial Fibrillation 40

Atrial Fibrillation Heart Transplant Atrial Flutter Transplant 40

Circulation: Arrhythmia and Electrophysiology

DECEMBER 21, 2023

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Inflammation may promote atrial fibrillation (AF) recurrence after catheter ablation. mg twice daily or placebo for 10 days. mg twice daily or placebo for 10 days. The first dose of the study drug was administered within 4 hours before ablation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Chest Pain Atrial Flutter 40

DAIC

OCTOBER 30, 2024

The Affera system was designed to address procedural challenges faced by the electrophysiology community while maintaining a high standard of safety and efficacy for patients. tim.hodson Wed, 10/30/2024 - 13:42 Oct. With this approval, Medtronic now offers two PFA technologies available for patients with Afib.

Ablation 52

Ablation AFIB Atrial Fibrillation Atrial Flutter 52

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Introduction The use of flecainide and propafenone for medical cardioversion of atrial fibrillation (AF) and atrial flutter/intra-atrial reentrant tachycardia (IART) is well-described in adults without congenital heart disease (CHD).

Congenital Heart Disease 40

Congenital Heart Disease Atrial Fibrillation Congenital Heart Disease 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

FAAM ablation successfully decreased the recurrence rate of atrial tachyarrhythmia compared with conventional non-PV foci ablation. Abstract Introduction Treatment of recurrent atrial fibrillation (AF) is sometimes challenging due to non-pulmonary vein (PV) foci. The RHYTHMIA system was used to perform all the procedures.

Ablation 40

Ablation Atrial Fibrillation Atrial Flutter Tachycardia 40